Where does Hinge Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Hinge Bio's 4 recorded funding rounds.

Premier Alternatives

Hinge Bio

Drug Discovery · Burlingame, CA · Founded 2015 · Privately Held (backing)

Operator of a biotech company intended to work for the development of a new class of flexible, extendible, and cooperatively binding therapeutics and diagnostics. Hinge Bio is based in Burlingame, CA and was founded in 2015. It was valued at $46 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $66.8 million across 4 recorded rounds; the latest was a $30.6 million early-stage round in Dec 2024.

PMV mark · valuation

$46.0M

Oct 2026

Priced at

its later-stage round

Jan 2025

Total raised

$66.8M

Last round

Early Stage VC

Dec 2024

Cap table — not yet on record

Hinge Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Hinge Bio with a free account

·The complete investor list: 13 names
·Watch Hinge Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Hinge Bio

Where does Hinge Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Hinge Bio's 4 recorded funding rounds.